Sustaining momentum: Can the FMEG surge hold in Q2?
Finolex delivered exceptional 53% PAT growth in Q1 FY27 on the back of strong volume growth and expanding margins. For Q2, the Street will watch whether the company can sustain this momentum and confirm FY27 guidance as capacity expansions begin to yield economies of scale.
The Q2 question: momentum or normalization?
Finolex delivered an exceptional Q1 FY27, with consolidated PAT surging 53% YoY to ₹249 Cr on the back of 44.3% revenue growth to ₹2,013 Cr. PBT margin expanded to 13.4% from 11.8% a year ago, and PAT margin to 10.7% from 9.6%. The board attributed the performance to strong volume growth, better operating leverage, and higher contribution from the branded FMEG segment (Fire, Medical, Electronics & General) — which the company targets to grow 48% to ₹400 Cr in FY27. The Street is pricing in this momentum: analyst consensus target is ₹1,200 (vs. current ₹1,192), and 8 of 9 analysts rate the stock Buy. For Q2, expectations are for the company to sustain these levels or post modest sequential growth — testing whether the margin and volume momentum can hold through seasonality and commodity input cycles.
~₹2,050 Cr
Maintaining Q1 run-rate or modest growth; cable demand tracking FY27 guidance of +14% for full year
~11–12%
In-line with FY27 guidance and Q1 delivery; FMEG contribution and capacity utilization key drivers
~₹225–250 Cr
Implies 10–15% YoY growth; market pricing for sustained execution
Key constituent
FY27 target ₹400 Cr (+48% YoY); higher margins and operating leverage critical to 12% PAT margin guidance
What a strong vs. weak quarter looks like
A strong quarter would show Q2 revenue >₹2,100 Cr (implying sequential growth or YoY growth >20%), PAT margin >11.5%, and an update on FMEG momentum (approaching ₹100+ Cr per quarter). Management guidance reaffirming FY27 targets and commenting on e-beam and fiber expansion completion (capex cycle winding down) would signal confidence in 12% margin sustainability. A weak quarter would reveal sequential revenue softness below ₹1,950 Cr, PAT margin compression below 10% (signaling input headwinds or FMEG underperformance), and any guidance revision downward. Cautious commentary on commodity input prices (copper, aluminum) or lumpy customer orders could dampen the narrative.
On track for FY27 guidance?
Yes, all visible indicators suggest Finolex is tracking its FY27 guidance. Q1 FY27 revenue of ₹2,013 Cr is already 28% of the ₹7,220 Cr consensus full-year target, implying an even run-rate through the remaining three quarters would deliver the guidance comfortably. Margin trajectory is strong at 13.4% PBT (vs 11.8% prior year), well-positioned to hit the 12% PAT margin guide. The FMEG segment, though a smaller mix today, is growing at 48% — the engine driving the margin profile. Analyst consensus for FY27 EPS is ₹48.10 (+18.1% growth), in line with the profit momentum. The only swing factor is commodity pricing: if copper/aluminum soften further, input cost tailwinds could improve margins further; if they spike, the company may need to pass through price increases, which could affect volume.
Recent filings & corporate actions
1 · Director re-appointments & Board stability
On Aug 11, 2026, Finolex's Board approved Q1 FY27 results and re-appointed three Independent Directors (Vanessa Singh, Zubin Billimoria, Sriraman Raghuraman) and Whole-Time Director Ratnakar Barve. All re-appointments were through special resolutions approved at the 58th AGM on Sep 28, 2026. This is routine housekeeping and signals governance continuity.
2 · Dividend action: 450% recommended for FY26
On Aug 27, 2026, Finolex recommended a dividend of 450% (₹9 per equity share) for FY26. This was approved at the AGM on Sep 28. Dividend record date is Sep 4, 2026, and ex-date is Aug 29, 2026 (already passed). This 450% payout (up from prior years) reflects strong earnings and cash generation, signaling management confidence in earnings sustainability.
3 · Insider trading window closed (pre-result quiet period)
On Sep 24, 2026, Finolex announced closure of its trading window for insiders, in compliance with SEBI insider trading regulations. This is standard pre-result practice and is now in effect (window closed until after result disclosure on Nov 7).
4 · Bulk deal activity (Aug 12): Routine
On Aug 12, 2026, Microcurves Trading Pvt Ltd executed a bulk sell of 8,58,286 shares @ ₹1,315.76, followed by a bulk buy at ₹1,314.53 on the same day. This appears to be a neutral repositioning by a trading entity; no promoter or insider involvement flagged. Routine liquidity activity.
5 · BRSR & ESG reporting (Sep 5)
Finolex filed its Business Responsibility and Sustainability Report (BRSR) for FY26 as part of its 58th Annual Report. This is routine governance and ESG compliance; no operational surprises expected.
What to watch on result day (Nov 7)
1 · Sequential and YoY revenue growth
Q1 FY27 was ₹2,013 Cr. Watch for Q2 to sustain this level or grow; YoY growth vs Q2 FY26 (₹1,375.79 Cr) should exceed 30% to confirm the momentum narrative. Growth <20% YoY would signal moderation.
2 · PBT and PAT margins
Q1 delivered 13.4% PBT and 10.7% PAT. Target is 12% PAT for FY27. Q2 margin >11% would confirm guidance; margin <10% would raise questions about commodity inputs or FMEG mix.
3 · FMEG segment update
Management commentary on FMEG volume, revenue, and margins is critical. Look for any update on the ₹400 Cr FY27 target and 48% growth trajectory. Quarterly burn-down will indicate run-rate feasibility.
4 · Capex & capacity expansion progress
E-beam and fiber expansion projects were underway as of Q1. Update on completion timeline and cost will help model FY28 margin and capex cycle normalization.
5 · FY27 guidance reaffirmation
Any commentary on FY27 revenue and margin guidance, particularly in light of commodity input trends and customer pipeline. Reaffirmation = confidence; revision = caution.
Finolex Cables is firing on all cylinders: Q1 FY27 delivered exceptional 53% PAT growth, margins expanded, and the high-margin FMEG segment is accelerating. The Street is aligned, with 8 of 9 analysts rating Buy at a median ₹1,200 target (vs. current ₹1,192). For Q2, the test is whether the company can sustain this momentum — maintaining revenue at or above ₹2,000 Cr and PAT margin at 11–12%. Commodity input pricing and FMEG contribution will be the swing factors. If Q2 confirms the trajectory and management reaffirms FY27 guidance, the stock has room to run toward the ₹1,348 bull target. If margins compress or growth modulates sharply, the ₹1,064 bear case comes into play. In the interim, the 450% dividend payout for FY26 and stable ownership (FII stable at 9.65%, DII +27bp to 16.70%) suggest institutional confidence in execution.